ClaraScience logoClaraScienceResearch-Grade Peptides
Longevity · Research Compound

MOTS-C Peptide Australia — 10mg, 99.1% Purity

Mitochondrial-derived peptide encoded by MT-RNR1. 16 amino acids. Exercise mimetic activating AMPK. Improves physical capacity and insulin sensitivity in mouse models (Lee et al., Cell Metab 2015). HPLC-verified 99.1% purity. Store at −20°C. Australian warehouse.

Purity99.1% HPLC verified
Concentration10mg per vial
PriceFrom $89.95 AUD
Storage−20°C recommended

What is MOTS-C?

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a 16-amino-acid peptide encoded within an open reading frame of the mitochondrial 12S ribosomal RNA gene (MT-RNR1). It was discovered and characterised by Chang Lee and colleagues at the University of Southern California in 2015, representing a novel class of mitochondrial-derived bioactive peptides (MDPs) that challenge the classical view of mitochondrial DNA as encoding only components of the respiratory chain.

The mechanistic interest in MOTS-C lies in its capacity to translocate from the mitochondria to the nucleus under conditions of metabolic stress, where it functions as a transcriptional regulator of nuclear gene programmes. Specifically, MOTS-C activates AMPK (AMP-activated protein kinase) — the primary cellular energy sensor that is also the key mediator of exercise-induced metabolic adaptations — through its effects on the folate cycle and AICAR accumulation.

ClaraScience supplies MOTS-C in 10mg lyophilised vials, HPLC-tested to ≥99.0% purity. Storage at −20°C is recommended for this compound. For laboratory research use only.

Origin. Encoded within mitochondrial DNA (MT-RNR1) — a mitochondrial-derived bioactive peptide, not a synthetic hormone analogue.
Mechanism. Activates AMPK via folate cycle/AICAR pathway — the same energy-sensing kinase activated by exercise and metformin.
Storage. −20°C recommended for this compound (unlike most peptides where 2–8°C suffices).

Research Background

The discovery of MOTS-C was published in Cell Metabolism by Lee et al. (2015;21:443–454) in a paper that introduced the concept of mitochondrial-derived peptides as a new class of bioactive signalling molecules. The paper demonstrated that MOTS-C administration in mice improved running capacity, body composition, and insulin sensitivity — effects partially recapitulating exercise training adaptations, which led to the "exercise mimetic" characterisation.

Subsequent research has investigated MOTS-C in multiple contexts including: insulin sensitivity and glucose disposal in skeletal muscle cells; mitochondrial stress responses; age-related physical decline models; and potential interactions with exercise training. Plasma MOTS-C levels have been observed to decline with age in human cross-sectional studies, adding to the research interest from a longevity biology perspective.

MOTS-C is frequently studied alongside NAD+ and SS-31 (Elamipretide) in comprehensive mitochondrial biology research programmes that investigate the interconnected systems of mitochondrial signalling, energy metabolism, and ageing.

Key citation Lee C et al. "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance." Cell Metab. 2015;21(3):443–454.

Compound Specifications

Common Name MOTS-C (Mitochondrial-derived peptide)
Structure 16 amino acids · MT-RNR1 encoded
Molecular Weight 2174.73 g/mol
Purity (HPLC) ≥99.0% (99.1% verified this batch)
Vial Size 10mg lyophilised powder
Storage −20°C recommended (unlike most peptides)
Primary Reference Lee C et al., Cell Metab 2015;21:443–454

Storage & Handling

Important: MOTS-C storage requirements differ from most peptides. −20°C storage is recommended for this compound.

  • Unopened vial: −20°C recommended. 2–8°C for short-term (up to 4 weeks) only.
  • After reconstitution: 2–8°C, use within 14 days. Minimise freeze-thaw cycles.
  • Reconstitution: Sterile bacteriostatic water. Use our free reconstitution calculator.

Full protocols: Storage & Handling Guide.

Ordering & Pricing — Australia

Quantity Price per vial Saving
1–4 vials $89.95 AUD
5–9 vials $79.95 AUD Save 11%
10+ vials $74.95 AUD Save 17%

Free priority tracked shipping on orders over $250 AUD. 24-hour dispatch. Wholesale enquiries welcome.

Add MOTS-C to Cart →

Frequently Asked Questions

What is MOTS-C?

MOTS-C is a 16-amino-acid peptide encoded within mitochondrial DNA (MT-RNR1 gene). It activates AMPK and regulates metabolic gene programmes in response to cellular energy stress. It is classified as a mitochondrial-derived peptide (MDP). For laboratory research use only.

Why is MOTS-C called an exercise mimetic?

MOTS-C activates AMPK — the primary energy-sensing kinase also activated by exercise. In mouse studies (Lee et al., Cell Metab 2015), MOTS-C improved running capacity and insulin sensitivity, partially replicating some metabolic effects of exercise training in preclinical models.

How does MOTS-C compare to SS-31?

MOTS-C and SS-31 (Elamipretide) both target mitochondrial biology but through very different mechanisms. MOTS-C activates nuclear AMPK signalling by translocating to the nucleus; SS-31 binds cardiolipin on the inner mitochondrial membrane to improve electron transport chain efficiency and reduce ROS production.

What storage temperature does MOTS-C require?

−20°C is recommended for MOTS-C — stricter than most peptides which tolerate 2–8°C. ClaraScience ships MOTS-C from our Australian warehouse.

Is MOTS-C available in Australia?

ClaraScience stocks MOTS-C in our Australian warehouse. 10mg vials, research-grade, dispatched within 24 hours. For laboratory research use only.